Literature DB >> 9562922

Evaluating the role of melatonin in the long-term treatment of delayed sleep phase syndrome (DSPS).

Y Dagan1, I Yovel, D Hallis, M Eisenstein, I Raichik.   

Abstract

Delayed sleep phase syndrome (DSPS) involves a mismatch between the usual daily schedule required by the individual's environment and his or her circadian sleep-wake pattern. Patients suffering from DSPS are treated with chronotherapy, light therapy, or melatonin administration. While chronotherapy and light therapy are demanding and difficult treatments that usually lead to compliance problems, melatonin administration is a relatively simple and easy treatment option. Previous studies carried out on relatively small samples of DSPS patients have shown that melatonin has a sleep-promoting and entraining action when taken in the evening. The present study, which accompanied routine treatment in our sleep clinic, examined the efficiency of melatonin treatment in a relatively large population of DSPS subjects by means of subjective reports. The 61 subjects, 37 males and 24 females, were diagnosed with DSPS by means of clinical assessment and actigraphy at our sleep clinic. Their mean pretreatment falling asleep and waking times were 03:09 (SD = 86.22 minutes) and 11:31 (SD = 98.58 minutes), respectively. They were treated with a 6-week course of 5 mg of oral melatonin taken daily at 22:00. A survey questionnaire was sent to the home of each subject 12-18 months after the end of the treatment; the survey investigated the efficiency of the melatonin treatment and its possible side effects. Of the patients, 96.7% reported that the melatonin treatment was helpful, with almost no side effects. Of these, 91.5% reported a relapse to their pretreatment sleeping patterns within 1 year of the end of treatment. Only 28.8% reported that the relapse occurred within 1 week. The pretreatment falling asleep and waking times of patients in whom the changes were retained for a relatively long period of time were significantly earlier than those of patients whose relapse was immediate (t = 2.18, p < .05; t = 2.39, p < .05, respectively), with no difference in sleep duration. The implications of these findings, as well as further research possibilities, are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9562922     DOI: 10.3109/07420529808998682

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  13 in total

1.  Circadian Rhythm Sleep Disorders.

Authors:  Min Ju Kim; Jung Hie Lee; Jeanne F Duffy
Journal:  J Clin Outcomes Manag       Date:  2013-11-01

2.  Circadian Rhythm Sleep Disorders.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-09       Impact factor: 3.598

Review 3.  Chronobiological disorders: current and prevalent conditions.

Authors:  Lia R A Bittencourt; Rogerio Santos-Silva; Marco T de Mello; Monica L Andersen; Sergio Tufik
Journal:  J Occup Rehabil       Date:  2010-03

Review 4.  The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis.

Authors:  Ingeborg M van Geijlswijk; Hubert P L M Korzilius; Marcel G Smits
Journal:  Sleep       Date:  2010-12       Impact factor: 5.849

5.  Therapeutics for Circadian Rhythm Sleep Disorders.

Authors:  Ehren R Dodson; Phyllis C Zee
Journal:  Sleep Med Clin       Date:  2010-12

6.  Increased sensitivity of the circadian system to light in delayed sleep-wake phase disorder.

Authors:  Lauren A Watson; Andrew J K Phillips; Ihaia T Hosken; Elise M McGlashan; Clare Anderson; Leon C Lack; Steven W Lockley; Shantha M W Rajaratnam; Sean W Cain
Journal:  J Physiol       Date:  2018-10-25       Impact factor: 5.182

7.  Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline.

Authors:  R Robert Auger; Helen J Burgess; Jonathan S Emens; Ludmila V Deriy; Sherene M Thomas; Katherine M Sharkey
Journal:  J Clin Sleep Med       Date:  2015-10-15       Impact factor: 4.062

Review 8.  Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review.

Authors:  Robert L Sack; Dennis Auckley; R Robert Auger; Mary A Carskadon; Kenneth P Wright; Michael V Vitiello; Irina V Zhdanova
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

Review 9.  Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report.

Authors:  Timothy I Morgenthaler; Teofilo Lee-Chiong; Cathy Alessi; Leah Friedman; R Nisha Aurora; Brian Boehlecke; Terry Brown; Andrew L Chesson; Vishesh Kapur; Rama Maganti; Judith Owens; Jeffrey Pancer; Todd J Swick; Rochelle Zak
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

Review 10.  The relevance of melatonin to sports medicine and science.

Authors:  Greg Atkinson; Barry Drust; Thomas Reilly; Jim Waterhouse
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.